Thomas R. Fuerst
Fundador en Neuimmune, Inc. .
Perfil
Thomas R.
Fuerst is the founder of Neuimmune, Inc. He worked as the Director of Molecular Genetics at MedImmune Ltd.
and as the Executive Director of Corporate Development at Sanofi Pasteur, Inc. He was also the Director of Vaccines and Biologics at the US Department of Health & Human Services.
Additionally, he served as the Vice President of Research & Development at Genelabs Technologies, Inc. and as the Chief Scientific Officer & Executive VP at PharmAthene, Inc. Fuerst holds an MBA from George Washington University, a doctorate from Cornell University, and an undergraduate degree from the University of California, Berkeley.
Cargos activos de Thomas R. Fuerst
| Empresas | Cargo | Inicio |
|---|---|---|
Neuimmune, Inc.
 Neuimmune, Inc. BiotechnologyHealth Technology Neuimmune, Inc. develops vaccines and biopharmaceuticals. The private company is based in Sykesville, MD. The company was founded by Nathan Lewis, Alexander K. Andrianov, Thomas R. Fuerst. | Fundador | - |
Antiguos cargos conocidos de Thomas R. Fuerst.
| Empresas | Cargo | Fin |
|---|---|---|
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Director Técnico/Científico/I+D | 19/10/2012 |
| US Department of Health & Human Services (DC) | Corporate Officer/Principal | 02/01/2010 |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Corporate Officer/Principal | - |
Sanofi Pasteur, Inc.
 Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Corporate Officer/Principal | - |
Formación de Thomas R. Fuerst.
| George Washington University | Masters Business Admin |
| Cornell University | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Health Technology |
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Sanofi Pasteur, Inc.
Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Health Technology |
| US Department of Health & Human Services (DC) | Government |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |
Neuimmune, Inc.
Neuimmune, Inc. BiotechnologyHealth Technology Neuimmune, Inc. develops vaccines and biopharmaceuticals. The private company is based in Sykesville, MD. The company was founded by Nathan Lewis, Alexander K. Andrianov, Thomas R. Fuerst. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas R. Fuerst
